162 related articles for article (PubMed ID: 19302482)
1. Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization.
Guerreiro S; Ponceau A; Toulorge D; Martin E; Alvarez-Fischer D; Hirsch EC; Michel PP
J Neurochem; 2009 May; 109(4):1118-28. PubMed ID: 19302482
[TBL] [Abstract][Full Text] [Related]
2. Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels.
Guerreiro S; Toulorge D; Hirsch E; Marien M; Sokoloff P; Michel PP
Mol Pharmacol; 2008 Oct; 74(4):980-9. PubMed ID: 18621927
[TBL] [Abstract][Full Text] [Related]
3. Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism.
Salthun-Lassalle B; Traver S; Hirsch EC; Michel PP
Mol Pharmacol; 2005 Nov; 68(5):1214-24. PubMed ID: 16077032
[TBL] [Abstract][Full Text] [Related]
4. The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress.
Traver S; Salthun-Lassalle B; Marien M; Hirsch EC; Colpaert F; Michel PP
Mol Pharmacol; 2005 Jun; 67(6):1882-91. PubMed ID: 15784847
[TBL] [Abstract][Full Text] [Related]
5. KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasis.
Toulorge D; Guerreiro S; Hirsch EC; Michel PP
J Neurochem; 2010 Jul; 114(2):553-64. PubMed ID: 20456014
[TBL] [Abstract][Full Text] [Related]
6. Particular vulnerability of rat mesencephalic dopaminergic neurons to tetrahydrobiopterin: Relevance to Parkinson's disease.
Lee SY; Moon Y; Hee Choi D; Jin Choi H; Hwang O
Neurobiol Dis; 2007 Jan; 25(1):112-20. PubMed ID: 17049260
[TBL] [Abstract][Full Text] [Related]
7. Uric acid and evolution.
Álvarez-Lario B; Macarrón-Vicente J
Rheumatology (Oxford); 2010 Nov; 49(11):2010-5. PubMed ID: 20627967
[TBL] [Abstract][Full Text] [Related]
8. Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity.
Du Y; Chen CP; Tseng CY; Eisenberg Y; Firestein BL
Glia; 2007 Apr; 55(5):463-72. PubMed ID: 17203476
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitor lactacystin disturbs the intracellular calcium homeostasis of dopamine neurons in ventral mesencephalic cultures.
Li X; Yang D; Li L; Peng C; Chen S; Le W
Neurochem Int; 2007 Jun; 50(7-8):959-65. PubMed ID: 17561309
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease.
Xu Q; Kanthasamy AG; Reddy MB
Toxicology; 2008 Mar; 245(1-2):101-8. PubMed ID: 18255213
[TBL] [Abstract][Full Text] [Related]
11. Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration.
Andreadou E; Nikolaou C; Gournaras F; Rentzos M; Boufidou F; Tsoutsou A; Zournas C; Zissimopoulos V; Vassilopoulos D
Clin Neurol Neurosurg; 2009 Nov; 111(9):724-8. PubMed ID: 19632030
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling.
Katsuki H; Kurimoto E; Takemori S; Kurauchi Y; Hisatsune A; Isohama Y; Izumi Y; Kume T; Shudo K; Akaike A
J Neurochem; 2009 Jul; 110(2):707-18. PubMed ID: 19457078
[TBL] [Abstract][Full Text] [Related]
13. Ethanol enhances GABAB-mediated inhibitory postsynaptic transmission on rat midbrain dopaminergic neurons by facilitating GIRK currents.
Federici M; Nisticò R; Giustizieri M; Bernardi G; Mercuri NB
Eur J Neurosci; 2009 Apr; 29(7):1369-77. PubMed ID: 19309316
[TBL] [Abstract][Full Text] [Related]
14. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure?
Duan X; Ling F
Med Hypotheses; 2008; 70(3):578-81. PubMed ID: 17689199
[TBL] [Abstract][Full Text] [Related]
15. Uric acid administration in patients with acute stroke: a novel approach to neuroprotection.
Amaro S; Planas AM; Chamorro A
Expert Rev Neurother; 2008 Feb; 8(2):259-70. PubMed ID: 18271711
[TBL] [Abstract][Full Text] [Related]
16. Caffeine and uric acid mediate glutathione synthesis for neuroprotection.
Aoyama K; Matsumura N; Watabe M; Wang F; Kikuchi-Utsumi K; Nakaki T
Neuroscience; 2011 May; 181():206-15. PubMed ID: 21371533
[TBL] [Abstract][Full Text] [Related]
17. Dopamine release in organotypic cultures of foetal mouse mesencephalon: effects of depolarizing agents, pargyline, nomifensine, tetrodotoxin and calcium.
Larsen TR; Rossen S; Gramsbergen JB
Eur J Neurosci; 2008 Aug; 28(3):569-76. PubMed ID: 18702728
[TBL] [Abstract][Full Text] [Related]
18. Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress.
Troadec JD; Marien M; Darios F; Hartmann A; Ruberg M; Colpaert F; Michel PP
J Neurochem; 2001 Oct; 79(1):200-10. PubMed ID: 11595772
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes.
Lim JH; Kim SS; Boo DH; No H; Kang BY; Kim EM; Hwang O; Choi HJ
Neurosci Lett; 2009 Feb; 451(3):185-9. PubMed ID: 19146917
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons.
Sotty F; Montezinho LP; Steiniger-Brach B; Nielsen J
J Neurochem; 2009 May; 109(3):766-75. PubMed ID: 19236563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
